Search
for
Sort by
Research 571–600 of 1000+
- Carvone Decreases Melanin Content by Inhibiting Melanoma Cell Proliferation via the Cyclic Adenosine Monophosphate (cAMP) Pathway
- A possible solution for hair loss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Cucurbitacin promotes hair growth in mice by inhibiting the expression of fibroblast growth factor 18
- Hispidulin ameliorates androgenetic alopecia by inhibiting dermal papilla cell ferroptosis via TRPML1 channel activation
- PLA2R1 Overexpression Causes Podocyte Injury by Inhibiting the Cell Cycle: A Clinical Cross-Sectional Investigation and Cellular Study
- BI02 (P97): Epidermal growth factor receptor inhibitor therapy induces a distinct inflammatory hair follicle response that includes a collapse of immune privilege
- Finasteride: A slow-binding 5.alpha.-reductase inhibitor
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Finasteride: the first 5 alpha-reductase inhibitor.
- The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen
- Finasteride: The First 5α-Reductase Inhibitor
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor
- The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men’s Health
- Finasteride: a 5 alpha-reductase inhibitor.
- Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
- Macular Abnormalities Associated With 5α-Reductase Inhibitor
- Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- The influence of low dose finasteride, a type II 5α-reductase inhibitor, on circulating neuroactive steroids
- In silico screening of effective inhibitor of 5α-reductase type 1 for androgenic alopecia treatment
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- BH02 Reversibility of 5-alpha reductase inhibitor effects on semen parameters: a review of human evidence
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in patients with breast cancer.
- Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review.